Self-Nucleic Acid Sensing: A Novel Crucial Pathway Involved in Obesity-Mediated Metaflammation and Metabolic Syndrome
Authors:
Open Access
- 26 January 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11
Abstract
Obesity and overweight are a global health problem affecting almost one third of the world population. There are multiple complications associated with obesity including metabolic syndrome that commonly lead to development of type II diabetes and non-alcoholic fatty liver disease. The development of metabolic syndrome and severe complications associated with obesity is attributed to the chronic low-grade inflammation that occurs in metabolic tissues such as the liver and the white adipose tissue. In recent years, nucleic acids (mostly DNA), which accumulate systemically in obese individuals, were shown to aberrantly activate innate immune responses and thus to contribute to metabolic tissue inflammation. This minireview will focus on (i) the main sources and forms of nucleic acids that accumulate during obesity, (ii) the sensing pathways required for their detection, and (iii) the key cellular players involved in this process. Fully elucidating the role of nucleic acids in the induction of inflammation induced by obesity would promote the identification of new and long-awaited therapeutic approaches to limit obesity-mediated complications.Keywords
This publication has 74 references indexed in Scilit:
- The shift of obesity burden by socioeconomic status between 1998 and 2017 in Latin America and the Caribbean: a cross-sectional series studyThe Lancet Global Health, 2019
- Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent MannerCell, 2019
- Properties and functions of adipose tissue macrophages in obesityImmunology, 2018
- Economic Burden of Obesity: A Systematic Literature ReviewInternational Journal of Environmental Research and Public Health, 2017
- Macrophages, Immunity, and Metabolic DiseaseImmunity, 2014
- Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with DiabetesNew England Journal of Medicine, 2012
- Treatment with Anakinra Improves Disposition Index But Not Insulin Sensitivity in Nondiabetic Subjects with the Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled StudyThe Journal of Clinical Endocrinology & Metabolism, 2011
- Treatment Modalities of ObesityDiabetes Care, 2008
- Effects of Etanercept in Patients With the Metabolic SyndromeArchives of internal medicine (1960), 2006
- ObesityNew England Journal of Medicine, 2002